Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.

PLoS One · 2014 · PMC3913686 · PMID 24504006

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These delays may be significant: in newborn infants living in areas of high infant mortality, delaying CMV acquisition by even 2–4 weeks could translate into morbidity and mortality benefits.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.